Lümmen P
Hoechst Schering AgrEvo, D-65926 Frankfurt/Main, Germany.
Biochim Biophys Acta. 1998 May 6;1364(2):287-96. doi: 10.1016/s0005-2728(98)00034-6.
Structurally diverse synthetic insecticides and acaricides had been shown to inhibit the proton-translocating NADH:ubiquinone oxidoreductase (complex I) activity. In addition, secondary metabolites from microbial and plant sources known to act on complex I exhibited biological activity against agricultural and environmental insect pests. Mechanistic studies indicated that these compounds interfered with ubiquinone reduction most likely at the same site(s) as the classical complex I inhibitors rotenone and piericidin A. Two approaches to characterize the mechanism of insecticidal/acaricidal complex I inhibitors were followed: enzyme kinetic studies and binding studies with radiolabeled inhibitors. Enzyme kinetic experiments were sometimes controversially interpreted regarding a competitive or non-competitive inhibitor mechanism with respect to the electron acceptor. In general, radioligand binding data with submitochondrial membranes were in line with the enzymological results but due to methodological drawbacks, saturation kinetic analyses were impossible. The main problems underlying many studies of inhibitor interaction with complex I were (i) the use of membrane-bound enzyme preparations and (ii) the physicochemical properties of the amphiphilic inhibitors with their strong tendency to accumulate in the membrane phase. A more recent approach to characterize inhbibitor interaction sites in complex I was the isolation of piericidin-resistant mutants of photosynthetic bacteria which produce a simpler homologue of mitochondrial NADH:Q oxidoreductase.
结构多样的合成杀虫剂和杀螨剂已被证明能抑制质子转运型NADH:泛醌氧化还原酶(复合体I)的活性。此外,已知作用于复合体I的微生物和植物来源的次生代谢产物对农业和环境害虫具有生物活性。机理研究表明,这些化合物最有可能在与经典复合体I抑制剂鱼藤酮和杀粉蝶菌素A相同的位点干扰泛醌的还原。采用了两种方法来表征杀虫/杀螨复合体I抑制剂的作用机制:酶动力学研究和用放射性标记抑制剂进行的结合研究。关于电子受体,酶动力学实验有时对竞争性或非竞争性抑制剂机制的解释存在争议。一般来说,用亚线粒体膜进行的放射性配体结合数据与酶学结果一致,但由于方法上的缺陷,无法进行饱和动力学分析。许多关于抑制剂与复合体I相互作用的研究存在的主要问题是:(i)使用膜结合酶制剂;(ii)两亲性抑制剂的物理化学性质使其极易在膜相中积累。最近一种表征复合体I中抑制剂相互作用位点的方法是分离光合细菌的杀粉蝶菌素抗性突变体,这些突变体产生一种比线粒体NADH:Q氧化还原酶更简单的同源物。